Rumen degradability and whole tract digestibility of flavonolignans from milk thistle (Silybum marianum) fruit expeller in dairy cows

Czech Journal of Animal Science

Volumn 56, Issue 6, 2011, Pages 269-278

  Krizova L ^a   Watzkova J ^a   Trinacty J ^a   Richter, M ^a   Buchta, M ^b  

^a Agriresearch Rapotin Ltd ^*  (Czech Republic)

^b spol s ro   (Czech Republic)

Author keywords

Digestibility; In sacco technique; Plasma; Silymarin complex

Indexed keywords

ANIMALIA; BOS; MEDICAGO SATIVA; SILYBUM MARIANUM; ZEA MAYS;

EID: 79960153030     PISSN: 12121819     EISSN: None     Source Type: Journal    
DOI: 10.17221/1285-cjas     Document Type: Article

References (41)

1. th ed. Association of Official Analytical Chemists, Arlington, USA, 1984, 1141 pp.
2. Arcari M., Brambilla A., Brandt A., Caponi R., Corsi G., Di Rella M., Solinas F., Wachter W.P. (1992): A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations. Bollettino Chimico Farmaceutico, 131, 205-209.
3. Blumenthal M., Goldberg A., Brinkmann J. (2000): Herbal Medicine. Integrative Medicine Communications: Newton.
4. Buzzelli G., Moscarella S., Giusti A., Duchini A., Marena C., Lampertico M. (1993): A pilot study on the liver protective effect of silybin- phosphatidylcholine complex (IdB1016) in chronic active hepatitis. International Journal of Clinical Pharmacology, Therapy and Toxicology, 31, 456-460. (Pubitemid 23262277)
5. Buzzelli G., Moscarella S., Barbagli S., Marena C., Gentilini P. (1994): Therapeutic effect of silipide in patients with chronic hepatitis C non-responders (NTs) to interferon (IFN) treatment. Journal of Hepatology, 21 (Suppl. 1), S100.
6. Chen W., Xia H., Wu W. (2005): Optimized preparation of silymarin dripping pills by a central composite design response surface method. Chinese Traditional and Herbal Drugs, 36, 679-683.
7. Dixit N., Baboota S., Kohli K., Ahmad S., Ali J. (2007): Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches. Indian Journal of Pharmacology, 39, 172-179. (Pubitemid 350005989)
8. Enjalbert F., Nicot M.C., Bayourthe C., Moncoulon R. (2001): Ketone bodies in milk and blood of dairy cows: Relationship between concentrations and utilization for detection of subclinical ketosis. Journal of Dairy Science, 84, 583-589. (Pubitemid 33609642)
9. Geishauser T., Leslie K., Tenhagi J., Bashiri A. (2000): Evaluation of eight cow-side ketone testes in milk for detection of subclinical ketosis in dairy cows. Journal of Dairy Science, 83, 296-299.
10. Giacomelli S., Gallo D., Apollonio P., Ferlini C., Distefano M., Morazzoni P., Riva A., Bombardelli E., Mancuso S., Scambia G. (2002): Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo activity of cisplatin. Life Sciences, 70, 1447-1459. (Pubitemid 34159100)
11. Giorgi R., Conti M., Pifferi G. (1989): Soluble derivative of silybin a method of preparing them and pharmaceutical composition containing them. US patent 4886791.
12. Gunaratna C., Zhang T. (2003): Application of liquid chromatography- electrospray ionization-ion trap mass spectrometry to investigate the metabolism of silibinin in human liver microsomes. Journal of Chromatography B, 794, 303-310. (Pubitemid 37101007)
13. Krečman V., škottová N., Walterová D., Ulrichová J., šimánek V. (1998): Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta Medica, 64, 138-142. (Pubitemid 28153273)
14. Křen V., Walterová D. (2005): Silybin and silymarin - new effects and applications. Biomedicine Papers, 149, 29-41.
15. th Eur. Congr. Biopharmaceutics and Pharmacokinetics, Geneva, April 17-19, 1990. European Journal of Drug Metabolism Pharmacokinetics, Special Issue 1990.
16. Luper S. (1998): A review of plants used in the treatment of liver disease: Part 1. Alternative Medicine Review, 3, 410-421. (Pubitemid 128709687)
17. Madaus R., Halbach G., Trost W. (1976): Salt of silymarin group with aminopolyhydroxy alcohols. U.S. patent 3994925.
18. Magliulo E., Gagliardi B., Fiori GP. (1978): Zur Wirkung von Silymarin bei der Behandlung der akuten Virushepatitis. Medizinische Klinik, 73, 1060-1065.
19. Mayer K.E., Myers R.P., Lee S.S. (2005): Silymarin treatment of viral hepatitis: a systematic review. Journal of Viral Hepatitis, 12, 559-567. (Pubitemid 41532486)
20. Morazzoni P., Bombardelli E. (1995): Silybum marianum (Carduus marianus). Fitoterapia, 66, 3-42.
21. Morazzoni P., Magistretti M.J., Giochetti C., Zanolo G. (1992): Comparative bioavailability of Silipide, a new flavonolignan complex, in rats. European Journal of Drug Metabolism and Pharmacokinetics, 17, 39-44.
22. Pares A., Planas R., Torres M., Caballeria J., Viver J.M., Acero D., Panes J., Rigau J., Santos J., Rodes J. (1998): Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. Journal of Hepatology, 28, 615-621. (Pubitemid 28167999)
23. Quercia V., Pierini N., Incarnato G.P., Papetti P., Gambero P. (1980): HPLC evaluation of the ratio between the antihepatotoxic constituents of Silybum marianum. Fitoterapia, 51, 297-301. (Pubitemid 11082843)
24. Rainone F. (2005): Milk Thistle. American Family Physician, 72, 1285-1288. (Pubitemid 43104260)
25. Rickling B., Hans B., Kramarczyk R., Krumbiegel G., Weyhenmeyer R. (1995): Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereoisomers in plasma using column switching with electrochemical detection and reverse-phase chromatography with ultraviolet detection. Journal of Chromatography B, 670, 267-277.
26. Saller R., Meier R., Brignoli R. (2001): The use of silymarin in the treatment of liver diseases. Drugs, 61, 2035-2063. (Pubitemid 33135182)
27. Šimánek V., Křen V., Ulrichová J., Vicar J., Cvak L. (2000): Silymarin: What is the name⋯? An appeal for the change of editorial policy. Hepatology, 32, 442-443.
28. Šimánek V., Škottová N., Bartek J., Psotová J., Kosina P., Balejová L., Ulrichová J. (2001): Extract from Silybum marianum as nutraceutical: a double blind placebocontrolled study in healthy young men. Czech Journal of Food Sciences, 19, 106-110.
29. škottová N., Kre?man V., Váňa P., Chmela Z., Ulrichová J., šimánek V. (2000): Effect of silymarin and silibinin-phosphatidylcholine complex on plasma and lipoprotein cholesterol, and oxidation of LDL in rats fed on high cholesterol diet supplemented with currant oil. Acta Universitatis Palackianae Olomucensis, Faculty of Medicine, 144, 55-58.
30. Sommer A. (ed.). (1994): Nutrient Requirement and Tables of Nutritional Values of Feedstuffs for Ruminants. Research Institute of Animal Nutrition, Pohorelice, 198 pp. (in Czech)
31. Tedesco D., Tava A., Domeneghini C., Costa A., Sciannimanico D., Tameni M. (2002): Dietary inclusion of silymarin in periparturum dairy cows: Effects on milk productivity, plasma metabolites and liver tissue. Journal of Dairy Science, 80 (Suppl. 1), 244 (Abstr.).
32. Tedesco D., Tameni M., Steidler S., Galletti S., Di Pierro F. (2003): Effect of silymarin and its phospholipid complex against AFM1 excretion in an organic dairy herd. Milchwissenschaft, 58, 416-419. (Pubitemid 36922448)
33. Tedesco D., Domeneghini C., Sciannimanico D., Tameni M., Steidler S., Galletti S. (2004a): Silymarin, a possible heopatoprotector in dairy cows: biochemical and histological observations. Journal of Veterinary Medicine A-Physiology, Pathology, Clinical Medicine, 51, 85-89. (Pubitemid 41794928)
34. Tedesco D., Tava A., Galletti S., Tameni M., Varisco G., Costa A., Steidler S. (2004b): Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows. Journal of Dairy Science, 87, 2239-2247. (Pubitemid 38978827)
35. Třináctý J., Šimek M., Komprda T. (1996): The influence of a nylon bag carrier on alfalfa crude protein degradability. Animal Feed Science Technology, 57, 129-137.
36. Valenzuela A., Guerra R., Videla L.A. (1986): Antioxidant properties of the flavonoids silybin and (+)-cyanidanol- 3: comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Medica, 52, 438-440. (Pubitemid 17226383)
37. Van Soest P.J., Robertson J.B., Lewis B.A. (1991): Methods for dietary fiber, neutral detergent fiber and nonstarch polysaccharides in relation to animal nutrition. Journal of Dairy Science, 74, 3583-3597.
38. Vojtíšek B., Hronová B., Hamřík J., Janková B. (1991): Milk thistle (Silybum marianum, L., GAERTN.) in feed rations administered to ketotic cows. Veterinární Medicina, 36, 321-330. (in Czech)
39. Vojtíšek B., Hronová B., Hamřík J., Janková B. (1993): Dietary silymarin in cows with various planes of nutrition in puerperal period. Živočišná výroba, 38, 981-1001. (in Czech)
40. Wang M., Grange L., Tao J., Reyes E. (1996): Hepatoprotective properties of Silybum marianum herbal preparation on ethanolinduced liver damage. Fitoterapia, 67, 166-171. (Pubitemid 26171983)
41. Wen Z., Dumas T.E., Schrieber S.J., Hawke R.L., Fried M.W., Smith P.C. (2008): Pharmacokinetics and metabolic profile of free, conjugated and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metabolism and Disposition, 36, 65-72.